Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 207

1.

Gamma Ventral Capsulotomy in Intractable Obsessive-Compulsive Disorder.

Rasmussen SA, Noren G, Greenberg BD, Marsland R, McLaughlin NC, Malloy PJ, Salloway SP, Strong DR, Eisen JL, Jenike MA, Rauch SL, Baer L, Lindquist C.

Biol Psychiatry. 2018 Sep 1;84(5):355-364. doi: 10.1016/j.biopsych.2017.11.034. Epub 2017 Dec 15.

2.

Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder.

Noh HJ, Tang R, Flannick J, O'Dushlaine C, Swofford R, Howrigan D, Genereux DP, Johnson J, van Grootheest G, Grünblatt E, Andersson E, Djurfeldt DR, Patel PD, Koltookian M, M Hultman C, Pato MT, Pato CN, Rasmussen SA, Jenike MA, Hanna GL, Stewart SE, Knowles JA, Ruhrmann S, Grabe HJ, Wagner M, Rück C, Mathews CA, Walitza S, Cath DC, Feng G, Karlsson EK, Lindblad-Toh K.

Nat Commun. 2017 Oct 17;8(1):774. doi: 10.1038/s41467-017-00831-x.

3.

LOWER POSTERIOR CINGULATE CORTEX GLUTATHIONE LEVELS IN OBSESSIVE-COMPULSIVE DISORDER.

Brennan BP, Jensen JE, Perriello C, Pope HG Jr, Jenike MA, Hudson JI, Rauch SL, Kaufman MJ.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2016 Feb 1;1(2):116-124.

4.

An Examination of Rostral Anterior Cingulate Cortex Function and Neurochemistry in Obsessive-Compulsive Disorder.

Brennan BP, Tkachenko O, Schwab ZJ, Juelich RJ, Ryan EM, Athey AJ, Pope HG, Jenike MA, Baker JT, Killgore WD, Hudson JI, Jensen JE, Rauch SL.

Neuropsychopharmacology. 2015 Jul;40(8):1866-76. doi: 10.1038/npp.2015.36. Epub 2015 Feb 9.

5.

Open-label study of duloxetine for the treatment of obsessive-compulsive disorder.

Dougherty DD, Corse AK, Chou T, Duffy A, Arulpragasam AR, Deckersbach T, Jenike MA, Keuthen NJ.

Int J Neuropsychopharmacol. 2015 Jan 30;18(2). pii: pyu062. doi: 10.1093/ijnp/pyu062. Print 2015.

6.

Brain white matter integrity and association with age at onset in pediatric obsessive-compulsive disorder.

Rosso IM, Olson EA, Britton JC, Stewart SE, Papadimitriou G, Killgore WD, Makris N, Wilhelm S, Jenike MA, Rauch SL.

Biol Mood Anxiety Disord. 2014 Dec 18;4(1):13. doi: 10.1186/s13587-014-0013-6. eCollection 2014.

7.

REDUCED DISGUST PROPENSITY IS ASSOCIATED WITH IMPROVEMENT IN CONTAMINATION/WASHING SYMPTOMS IN OBSESSIVE-COMPULSIVE DISORDER.

Athey AJ, Elias JA, Crosby JM, Jenike MA, Pope HG Jr, Hudson JI, Brennan BP.

J Obsessive Compuls Relat Disord. 2015 Jan 1;4:20-24.

8.

Cross-disorder genome-wide analyses suggest a complex genetic relationship between Tourette's syndrome and OCD.

Yu D, Mathews CA, Scharf JM, Neale BM, Davis LK, Gamazon ER, Derks EM, Evans P, Edlund CK, Crane J, Fagerness JA, Osiecki L, Gallagher P, Gerber G, Haddad S, Illmann C, McGrath LM, Mayerfeld C, Arepalli S, Barlassina C, Barr CL, Bellodi L, Benarroch F, Berrió GB, Bienvenu OJ, Black DW, Bloch MH, Brentani H, Bruun RD, Budman CL, Camarena B, Campbell DD, Cappi C, Silgado JC, Cavallini MC, Chavira DA, Chouinard S, Cook EH, Cookson MR, Coric V, Cullen B, Cusi D, Delorme R, Denys D, Dion Y, Eapen V, Egberts K, Falkai P, Fernandez T, Fournier E, Garrido H, Geller D, Gilbert DL, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Hardy J, Heiman GA, Hemmings SM, Herrera LD, Hezel DM, Hoekstra PJ, Jankovic J, Kennedy JL, King RA, Konkashbaev AI, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Lupoli S, Macciardi F, Maier W, Manunta P, Marconi M, McCracken JT, Mesa Restrepo SC, Moessner R, Moorjani P, Morgan J, Muller H, Murphy DL, Naarden AL, Nurmi E, Ochoa WC, Ophoff RA, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner T, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosário MC, Rosenberg D, Ruhrmann S, Sabatti C, Salvi E, Sampaio AS, Samuels J, Sandor P, Service SK, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Turiel M, Valencia Duarte AV, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Weale M, Weiss R, Wendland JR, Westenberg HG, Shugart YY, Hounie AG, Miguel EC, Nicolini H, Wagner M, Ruiz-Linares A, Cath DC, McMahon W, Posthuma D, Oostra BA, Nestadt G, Rouleau GA, Purcell S, Jenike MA, Heutink P, Hanna GL, Conti DV, Arnold PD, Freimer NB, Stewart SE, Knowles JA, Cox NJ, Pauls DL.

Am J Psychiatry. 2015 Jan;172(1):82-93. doi: 10.1176/appi.ajp.2014.13101306. Epub 2014 Oct 31.

9.

Copy number variation in obsessive-compulsive disorder and tourette syndrome: a cross-disorder study.

McGrath LM, Yu D, Marshall C, Davis LK, Thiruvahindrapuram B, Li B, Cappi C, Gerber G, Wolf A, Schroeder FA, Osiecki L, O'Dushlaine C, Kirby A, Illmann C, Haddad S, Gallagher P, Fagerness JA, Barr CL, Bellodi L, Benarroch F, Bienvenu OJ, Black DW, Bloch MH, Bruun RD, Budman CL, Camarena B, Cath DC, Cavallini MC, Chouinard S, Coric V, Cullen B, Delorme R, Denys D, Derks EM, Dion Y, Rosário MC, Eapen V, Evans P, Falkai P, Fernandez TV, Garrido H, Geller D, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Grünblatt E, Heiman GA, Hemmings SM, Herrera LD, Hounie AG, Jankovic J, Kennedy JL, King RA, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Lochner C, Lowe TL, Lyon GJ, Macciardi F, Maier W, McCracken JT, McMahon W, Murphy DL, Naarden AL, Neale BM, Nurmi E, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Reus VI, Richter MA, Riddle M, Robertson MM, Rosenberg D, Rouleau GA, Ruhrmann S, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Tischfield JA, Vallada H, Veenstra-VanderWeele J, Walitza S, Wang Y, Wendland JR, Shugart YY, Miguel EC, Nicolini H, Oostra BA, Moessner R, Wagner M, Ruiz-Linares A, Heutink P, Nestadt G, Freimer N, Petryshen T, Posthuma D, Jenike MA, Cox NJ, Hanna GL, Brentani H, Scherer SW, Arnold PD, Stewart SE, Mathews CA, Knowles JA, Cook EH, Pauls DL, Wang K, Scharf JM.

J Am Acad Child Adolesc Psychiatry. 2014 Aug;53(8):910-9. doi: 10.1016/j.jaac.2014.04.022. Epub 2014 Jun 24.

10.

Intensive residential treatment for severe obsessive-compulsive disorder: characterizing treatment course and predictors of response.

Brennan BP, Lee C, Elias JA, Crosby JM, Mathes BM, Andre MC, Gironda CM, Pope HG Jr, Jenike MA, Fitzmaurice GM, Hudson JI.

J Psychiatr Res. 2014 Sep;56:98-105. doi: 10.1016/j.jpsychires.2014.05.008. Epub 2014 May 23.

11.

Partitioning the heritability of Tourette syndrome and obsessive compulsive disorder reveals differences in genetic architecture.

Davis LK, Yu D, Keenan CL, Gamazon ER, Konkashbaev AI, Derks EM, Neale BM, Yang J, Lee SH, Evans P, Barr CL, Bellodi L, Benarroch F, Berrio GB, Bienvenu OJ, Bloch MH, Blom RM, Bruun RD, Budman CL, Camarena B, Campbell D, Cappi C, Cardona Silgado JC, Cath DC, Cavallini MC, Chavira DA, Chouinard S, Conti DV, Cook EH, Coric V, Cullen BA, Deforce D, Delorme R, Dion Y, Edlund CK, Egberts K, Falkai P, Fernandez TV, Gallagher PJ, Garrido H, Geller D, Girard SL, Grabe HJ, Grados MA, Greenberg BD, Gross-Tsur V, Haddad S, Heiman GA, Hemmings SM, Hounie AG, Illmann C, Jankovic J, Jenike MA, Kennedy JL, King RA, Kremeyer B, Kurlan R, Lanzagorta N, Leboyer M, Leckman JF, Lennertz L, Liu C, Lochner C, Lowe TL, Macciardi F, McCracken JT, McGrath LM, Mesa Restrepo SC, Moessner R, Morgan J, Muller H, Murphy DL, Naarden AL, Ochoa WC, Ophoff RA, Osiecki L, Pakstis AJ, Pato MT, Pato CN, Piacentini J, Pittenger C, Pollak Y, Rauch SL, Renner TJ, Reus VI, Richter MA, Riddle MA, Robertson MM, Romero R, Rosàrio MC, Rosenberg D, Rouleau GA, Ruhrmann S, Ruiz-Linares A, Sampaio AS, Samuels J, Sandor P, Sheppard B, Singer HS, Smit JH, Stein DJ, Strengman E, Tischfield JA, Valencia Duarte AV, Vallada H, Van Nieuwerburgh F, Veenstra-Vanderweele J, Walitza S, Wang Y, Wendland JR, Westenberg HG, Shugart YY, Miguel EC, McMahon W, Wagner M, Nicolini H, Posthuma D, Hanna GL, Heutink P, Denys D, Arnold PD, Oostra BA, Nestadt G, Freimer NB, Pauls DL, Wray NR, Stewart SE, Mathews CA, Knowles JA, Cox NJ, Scharf JM.

PLoS Genet. 2013 Oct;9(10):e1003864. doi: 10.1371/journal.pgen.1003864. Epub 2013 Oct 24.

12.

Meta-analysis of association between obsessive-compulsive disorder and the 3' region of neuronal glutamate transporter gene SLC1A1.

Stewart SE, Mayerfeld C, Arnold PD, Crane JR, O'Dushlaine C, Fagerness JA, Yu D, Scharf JM, Chan E, Kassam F, Moya PR, Wendland JR, Delorme R, Richter MA, Kennedy JL, Veenstra-VanderWeele J, Samuels J, Greenberg BD, McCracken JT, Knowles JA, Fyer AJ, Rauch SL, Riddle MA, Grados MA, Bienvenu OJ, Cullen B, Wang Y, Shugart YY, Piacentini J, Rasmussen S, Nestadt G, Murphy DL, Jenike MA, Cook EH, Pauls DL, Hanna GL, Mathews CA.

Am J Med Genet B Neuropsychiatr Genet. 2013 Jun;162B(4):367-79. doi: 10.1002/ajmg.b.32137. Epub 2013 Apr 18.

PMID:
23606572
13.

DBT-enhanced cognitive-behavioral treatment for trichotillomania: A randomized controlled trial.

Keuthen NJ, Rothbaum BO, Fama J, Altenburger E, Falkenstein MJ, Sprich SE, Kearns M, Meunier S, Jenike MA, Welch SS.

J Behav Addict. 2012 Sep;1(3):106-14. doi: 10.1556/JBA.1.2012.003.

PMID:
26165460
14.

Genome-wide association study of obsessive-compulsive disorder.

Stewart SE, Yu D, Scharf JM, Neale BM, Fagerness JA, Mathews CA, Arnold PD, Evans PD, Gamazon ER, Davis LK, Osiecki L, McGrath L, Haddad S, Crane J, Hezel D, Illman C, Mayerfeld C, Konkashbaev A, Liu C, Pluzhnikov A, Tikhomirov A, Edlund CK, Rauch SL, Moessner R, Falkai P, Maier W, Ruhrmann S, Grabe HJ, Lennertz L, Wagner M, Bellodi L, Cavallini MC, Richter MA, Cook EH Jr, Kennedy JL, Rosenberg D, Stein DJ, Hemmings SM, Lochner C, Azzam A, Chavira DA, Fournier E, Garrido H, Sheppard B, Umaña P, Murphy DL, Wendland JR, Veenstra-VanderWeele J, Denys D, Blom R, Deforce D, Van Nieuwerburgh F, Westenberg HG, Walitza S, Egberts K, Renner T, Miguel EC, Cappi C, Hounie AG, Conceição do Rosário M, Sampaio AS, Vallada H, Nicolini H, Lanzagorta N, Camarena B, Delorme R, Leboyer M, Pato CN, Pato MT, Voyiaziakis E, Heutink P, Cath DC, Posthuma D, Smit JH, Samuels J, Bienvenu OJ, Cullen B, Fyer AJ, Grados MA, Greenberg BD, McCracken JT, Riddle MA, Wang Y, Coric V, Leckman JF, Bloch M, Pittenger C, Eapen V, Black DW, Ophoff RA, Strengman E, Cusi D, Turiel M, Frau F, Macciardi F, Gibbs JR, Cookson MR, Singleton A; North American Brain Expression Consortium, Hardy J; UK Brain Expression Database, Crenshaw AT, Parkin MA, Mirel DB, Conti DV, Purcell S, Nestadt G, Hanna GL, Jenike MA, Knowles JA, Cox N, Pauls DL.

Mol Psychiatry. 2013 Jul;18(7):788-98. doi: 10.1038/mp.2012.85. Epub 2012 Aug 14. Erratum in: Mol Psychiatry. 2013 Jul;18(7):843. Davis, L K [added].

15.

DBT-enhanced habit reversal treatment for trichotillomania: 3-and 6-month follow-up results.

Keuthen NJ, Rothbaum BO, Falkenstein MJ, Meunier S, Timpano KR, Jenike MA, Welch SS.

Depress Anxiety. 2011 Apr;28(4):310-3. doi: 10.1002/da.20778. Epub 2010 Dec 15.

PMID:
21456040
16.

Depression in comorbid obsessive-compulsive disorder and posttraumatic stress disorder.

Merrill A, Gershuny B, Baer L, Jenike MA.

J Clin Psychol. 2011 Jun;67(6):624-8. doi: 10.1002/jclp.20783. Epub 2011 Mar 14.

PMID:
21404272
17.

Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder.

Delucchi KL, Katerberg H, Stewart SE, Denys DA, Lochner C, Stack DE, den Boer JA, van Balkom AJ, Jenike MA, Stein DJ, Cath DC, Mathews CA.

Compr Psychiatry. 2011 May-Jun;52(3):334-41. doi: 10.1016/j.comppsych.2010.06.007. Epub 2010 Aug 5.

18.

Double-blind, placebo-controlled trial of topiramate augmentation in treatment-resistant obsessive-compulsive disorder.

Berlin HA, Koran LM, Jenike MA, Shapira NA, Chaplin W, Pallanti S, Hollander E.

J Clin Psychiatry. 2011 May;72(5):716-21. doi: 10.4088/JCP.09m05266gre. Epub 2010 Aug 10.

PMID:
20816027
19.

Cognitive inflexibility and frontal-cortical activation in pediatric obsessive-compulsive disorder.

Britton JC, Rauch SL, Rosso IM, Killgore WD, Price LM, Ragan J, Chosak A, Hezel DM, Pine DS, Leibenluft E, Pauls DL, Jenike MA, Stewart SE.

J Am Acad Child Adolesc Psychiatry. 2010 Sep;49(9):944-53. doi: 10.1016/j.jaac.2010.05.006. Epub 2010 Jun 29.

20.

Pilot trial of dialectical behavior therapy-enhanced habit reversal for trichotillomania.

Keuthen NJ, Rothbaum BO, Welch SS, Taylor C, Falkenstein M, Heekin M, Jordan CA, Timpano K, Meunier S, Fama J, Jenike MA.

Depress Anxiety. 2010 Oct;27(10):953-9. doi: 10.1002/da.20732.

PMID:
20721929
21.

Amygdala activation in response to facial expressions in pediatric obsessive-compulsive disorder.

Britton JC, Stewart SE, Killgore WD, Rosso IM, Price LM, Gold AL, Pine DS, Wilhelm S, Jenike MA, Rauch SL.

Depress Anxiety. 2010 Jul;27(7):643-51. doi: 10.1002/da.20718.

22.

Symptom dimensions in OCD: item-level factor analysis and heritability estimates.

Katerberg H, Delucchi KL, Stewart SE, Lochner C, Denys DA, Stack DE, Andresen JM, Grant JE, Kim SW, Williams KA, den Boer JA, van Balkom AJ, Smit JH, van Oppen P, Polman A, Jenike MA, Stein DJ, Mathews CA, Cath DC.

Behav Genet. 2010 Jul;40(4):505-17. doi: 10.1007/s10519-010-9339-z. Epub 2010 Apr 2.

23.

A single-blinded case-control study of memantine in severe obsessive-compulsive disorder.

Stewart SE, Jenike EA, Hezel DM, Stack DE, Dodman NH, Shuster L, Jenike MA.

J Clin Psychopharmacol. 2010 Feb;30(1):34-9. doi: 10.1097/JCP.0b013e3181c856de.

PMID:
20075645
24.

Long-term outcome following Intensive Residential Treatment of Obsessive-Compulsive Disorder.

Stewart SE, Stack DE, Tsilker S, Alosso J, Stephansky M, Hezel DM, Jenike EA, Haddad SA, Kant J, Jenike MA.

J Psychiatr Res. 2009 Sep;43(13):1118-23. doi: 10.1016/j.jpsychires.2009.03.012. Epub 2009 May 5.

PMID:
19419736
25.

Four-factor structure of obsessive-compulsive disorder symptoms in children, adolescents, and adults.

Stewart SE, Rosario MC, Baer L, Carter AS, Brown TA, Scharf JM, Illmann C, Leckman JF, Sukhodolsky D, Katsovich L, Rasmussen S, Goodman W, Delorme R, Leboyer M, Chabane N, Jenike MA, Geller DA, Pauls DL.

J Am Acad Child Adolesc Psychiatry. 2008 Jul;47(7):763-772. doi: 10.1097/CHI.0b013e318172ef1e.

PMID:
18520961
26.

Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.

Wilhelm S, Buhlmann U, Tolin DF, Meunier SA, Pearlson GD, Reese HE, Cannistraro P, Jenike MA, Rauch SL.

Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409. doi: 10.1176/appi.ajp.2007.07050776. Epub 2008 Feb 1.

PMID:
18245177
27.

Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Stewart SE, Fagerness JA, Platko J, Smoller JW, Scharf JM, Illmann C, Jenike E, Chabane N, Leboyer M, Delorme R, Jenike MA, Pauls DL.

Am J Med Genet B Neuropsychiatr Genet. 2007 Dec 5;144B(8):1027-33.

PMID:
17894418
28.

Trauma and posttraumatic stress disorder in treatment-resistant obsessive-compulsive disorder.

Gershuny BS, Baer L, Parker H, Gentes EL, Infield AL, Jenike MA.

Depress Anxiety. 2008;25(1):69-71.

PMID:
17318836
29.

A genetic family-based association study of OLIG2 in obsessive-compulsive disorder.

Stewart SE, Platko J, Fagerness J, Birns J, Jenike E, Smoller JW, Perlis R, Leboyer M, Delorme R, Chabane N, Rauch SL, Jenike MA, Pauls DL.

Arch Gen Psychiatry. 2007 Feb;64(2):209-14.

PMID:
17283288
30.

A magnetic resonance imaging study of regional cortical volumes following stereotactic anterior cingulotomy.

Rauch SL, Makris N, Cosgrove GR, Kim H, Cassem EH, Price BH, Baer L, Savage CR, Caviness VS Jr, Jenike MA, Kennedy DN.

CNS Spectr. 2001 Mar;6(3):214-22.

PMID:
16951656
31.

Current posttraumatic stress disorder and history of trauma in trichotillomania.

Gershuny BS, Keuthen NJ, Gentes EL, Russo AR, Emmott EC, Jameson M, Dougherty DD, Loh R, Jenike MA.

J Clin Psychol. 2006 Dec;62(12):1521-9.

PMID:
16897695
32.

Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both?

Dougherty DD, Loh R, Jenike MA, Keuthen NJ.

J Clin Psychiatry. 2006 Jul;67(7):1086-92.

PMID:
16889452
33.

Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment.

Stewart SE, Yen CH, Stack DE, Jenike MA.

J Psychiatr Res. 2006 Sep;40(6):511-9. Epub 2005 Oct 17.

PMID:
16229857
34.

Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder.

Stewart SE, Stack DE, Farrell C, Pauls DL, Jenike MA.

J Psychiatr Res. 2005 Nov;39(6):603-9. Epub 2005 Mar 4.

PMID:
16157162
35.

Severe obsessive-compulsive disorder with and without comorbid hair pulling: comparisons and clinical implications.

Stewart SE, Jenike MA, Keuthen NJ.

J Clin Psychiatry. 2005 Jul;66(7):864-9.

PMID:
16013902
36.

Visuospatial abilities, memory, and executive functioning in trichotillomania and obsessive-compulsive disorder.

Bohne A, Savage CR, Deckersbach T, Keuthen NJ, Jenike MA, Tuschen-Caffier B, Wilhelm S.

J Clin Exp Neuropsychol. 2005 May;27(4):385-99.

PMID:
15962686
37.

Pharmacotherapy for obsessive-compulsive disorder.

Dougherty DD, Rauch SL, Jenike MA.

J Clin Psychol. 2004 Nov;60(11):1195-202.

PMID:
15389617
38.

Interpretive biases for ambiguous information in body dysmorphic disorder.

Buhlmann U, Wilhelm S, McNally RJ, Tuschen-Caffier B, Baer L, Jenike MA.

CNS Spectr. 2002 Jun;7(6):435-6, 441-3.

PMID:
15107765
39.

Clinical practice. Obsessive-compulsive disorder.

Jenike MA.

N Engl J Med. 2004 Jan 15;350(3):259-65. Review. No abstract available.

PMID:
14724305
40.

Connections among symptoms of obsessive-compulsive disorder and posttraumatic stress disorder: a case series.

Gershuny BS, Baer L, Radomsky AS, Wilson KA, Jenike MA.

Behav Res Ther. 2003 Sep;41(9):1029-41.

PMID:
12914805
41.

A preliminary morphometric magnetic resonance imaging study of regional brain volumes in body dysmorphic disorder.

Rauch SL, Phillips KA, Segal E, Makris N, Shin LM, Whalen PJ, Jenike MA, Caviness VS Jr, Kennedy DN.

Psychiatry Res. 2003 Jan 20;122(1):13-9.

PMID:
12589879
42.

Prevalence of symptoms of body dysmorphic disorder and its correlates: a cross-cultural comparison.

Bohne A, Keuthen NJ, Wilhelm S, Deckersbach T, Jenike MA.

Psychosomatics. 2002 Nov-Dec;43(6):486-90.

PMID:
12444232
43.

Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study.

Rauch SL, Shin LM, Dougherty DD, Alpert NM, Fischman AJ, Jenike MA.

Neuropsychopharmacology. 2002 Nov;27(5):782-91.

44.

A study of parallel implicit and explicit information processing in patients with obsessive-compulsive disorder.

Deckersbach T, Savage CR, Curran T, Bohne A, Wilhelm S, Baer L, Jenike MA, Rauch SL.

Am J Psychiatry. 2002 Oct;159(10):1780-2.

PMID:
12359688
45.

Cognitive-behavior therapy for self-injurious skin picking. A case series.

Deckersbach T, Wilhelm S, Keuthen NJ, Baer L, Jenike MA.

Behav Modif. 2002 Jul;26(3):361-77.

PMID:
12080906
46.

Skin picking in German students. Prevalence, phenomenology, and associated characteristics.

Bohne A, Wilhelm S, Keuthen NJ, Baer L, Jenike MA.

Behav Modif. 2002 Jul;26(3):320-39.

PMID:
12080904
47.

Comorbid posttraumatic stress disorder: impact on treatment outcome for obsessive-compulsive disorder.

Gershuny BS, Baer L, Jenike MA, Minichiello WE, Wilhelm S.

Am J Psychiatry. 2002 May;159(5):852-4.

PMID:
11986141
48.

Prevalence of body dysmorphic disorder in a German college student sample.

Bohne A, Wilhelm S, Keuthen NJ, Florin I, Baer L, Jenike MA.

Psychiatry Res. 2002 Jan 31;109(1):101-4.

PMID:
11850057
49.

Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder.

Dougherty DD, Baer L, Cosgrove GR, Cassem EH, Price BH, Nierenberg AA, Jenike MA, Rauch SL.

Am J Psychiatry. 2002 Feb;159(2):269-75.

PMID:
11823270
50.

Symptom stability in adult obsessive-compulsive disorder: data from a naturalistic two-year follow-up study.

Mataix-Cols D, Rauch SL, Baer L, Eisen JL, Shera DM, Goodman WK, Rasmussen SA, Jenike MA.

Am J Psychiatry. 2002 Feb;159(2):263-8.

PMID:
11823269

Supplemental Content

Loading ...
Support Center